Sodium cromoglycate in nocturnal asthma. 1986

A D Morgan, and J J Connaughton, and J R Catterall, and C M Shapiro, and N J Douglas, and D C Flenley

To investigate whether mast cell degranulation was important in producing nocturnal asthma, the effect of a single high dose of nebulised sodium cromoglycate on overnight bronchoconstriction, oxygen saturation, and breathing patterns in eight patients with nocturnal wheeze was examined. The study took the form of a double blind placebo controlled crossover comparison. Treatment with cromoglycate did not reduce the overnight fall in FEV1 or FVC, although it was associated with improved nocturnal oxygenation. This study suggests that mast cell degranulation may not be important in the pathogenesis of nocturnal asthma.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004205 Cromolyn Sodium A chromone complex that acts by inhibiting the release of chemical mediators from sensitized MAST CELLS. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack. Disodium Cromoglycate,Sodium Cromoglycate,Aarane,Bicromat Spray,Cromoglicic Acid,Cromoglycate,Cromoglycic Acid,Cromolyn,FPL-670,Intal,Lomudal,Nalcrom,Nasalcrom,Opticrom,Vicrom,Acid, Cromoglicic,Acid, Cromoglycic,Cromoglycate, Disodium,Cromoglycate, Sodium,FPL 670,FPL670
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A D Morgan, and J J Connaughton, and J R Catterall, and C M Shapiro, and N J Douglas, and D C Flenley
October 1985, Thorax,
A D Morgan, and J J Connaughton, and J R Catterall, and C M Shapiro, and N J Douglas, and D C Flenley
November 2001, Thorax,
A D Morgan, and J J Connaughton, and J R Catterall, and C M Shapiro, and N J Douglas, and D C Flenley
April 2001, Thorax,
A D Morgan, and J J Connaughton, and J R Catterall, and C M Shapiro, and N J Douglas, and D C Flenley
February 1976, British medical journal,
A D Morgan, and J J Connaughton, and J R Catterall, and C M Shapiro, and N J Douglas, and D C Flenley
June 1978, British medical journal,
A D Morgan, and J J Connaughton, and J R Catterall, and C M Shapiro, and N J Douglas, and D C Flenley
May 1978, British medical journal,
A D Morgan, and J J Connaughton, and J R Catterall, and C M Shapiro, and N J Douglas, and D C Flenley
August 1981, Harefuah,
A D Morgan, and J J Connaughton, and J R Catterall, and C M Shapiro, and N J Douglas, and D C Flenley
January 1974, Plucne bolesti i tuberkuloza,
A D Morgan, and J J Connaughton, and J R Catterall, and C M Shapiro, and N J Douglas, and D C Flenley
October 1983, Lancet (London, England),
A D Morgan, and J J Connaughton, and J R Catterall, and C M Shapiro, and N J Douglas, and D C Flenley
January 2003, The Cochrane database of systematic reviews,
Copied contents to your clipboard!